Tumour model

HMy2.CIR

XenograftIn vitro

Model characteristics

Organism
Human
Tissue of origin
B cells
Pathology
Model type
In vitro, Xenograft
Availability
2 to 3 weeks

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Human
B cells
Mantle cells lymphoma
XenograftIn vitro
Human
B cells
B-cell acute lymphoblastic leukemia
XenograftIn vitro
Human
B cells
Burkitt's lymphoma
XenograftIn vitroResistant
Human
B cells
XenograftIn vitro

RL

Human
B cells
Follicular lymphoma
XenograftIn vitroResistant
Human
B cells
Chronic myelogenous leukemia
XenograftIn vitro